716 related articles for article (PubMed ID: 28645263)
1. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
[TBL] [Abstract][Full Text] [Related]
2. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
4. The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages.
Missailidis C; Neogi U; Stenvinkel P; Trøseid M; Nowak P; Bergman P
AIDS; 2018 Jul; 32(12):1589-1598. PubMed ID: 29620717
[TBL] [Abstract][Full Text] [Related]
5. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
6. Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection.
Haissman JM; Knudsen A; Hoel H; Kjær A; Kristoffersen US; Berge RK; Katzenstein TL; Svardal A; Ueland T; Aukrust P; Lebech AM; Nielsen SD; Trøseid M
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):130-6. PubMed ID: 26413854
[TBL] [Abstract][Full Text] [Related]
7. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
8. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
9. HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation.
Hove-Skovsgaard M; Gaardbo JC; Kolte L; Winding K; Seljeflot I; Svardal A; Berge RK; Gerstoft J; Ullum H; Trøseid M; Nielsen SD
BMC Infect Dis; 2017 Mar; 17(1):234. PubMed ID: 28356058
[TBL] [Abstract][Full Text] [Related]
10. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
[TBL] [Abstract][Full Text] [Related]
12. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous targeted analysis of trimethylamine-N-oxide, choline, betaine, and carnitine by high performance liquid chromatography tandem mass spectrometry.
Liu J; Zhao M; Zhou J; Liu C; Zheng L; Yin Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1035():42-48. PubMed ID: 27669507
[TBL] [Abstract][Full Text] [Related]
14. Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected Adults.
Sinha A; Ma Y; Scherzer R; Rahalkar S; Neilan BD; Crane H; Drozd D; Martin J; Deeks SG; Hunt P; Hsue PY
J Am Heart Assoc; 2019 May; 8(9):e011037. PubMed ID: 31030595
[TBL] [Abstract][Full Text] [Related]
15. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Tang WH; Wang Z; Levison BS; Koeth RA; Britt EB; Fu X; Wu Y; Hazen SL
N Engl J Med; 2013 Apr; 368(17):1575-84. PubMed ID: 23614584
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
[TBL] [Abstract][Full Text] [Related]
17. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
18. Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
Guo F; Dai Q; Zeng X; Liu Y; Tan Z; Zhang H; Ouyang D
Int Urol Nephrol; 2021 Mar; 53(3):539-551. PubMed ID: 32945995
[TBL] [Abstract][Full Text] [Related]
19. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults.
Chen YM; Liu Y; Zhou RF; Chen XL; Wang C; Tan XY; Wang LJ; Zheng RD; Zhang HW; Ling WH; Zhu HL
Sci Rep; 2016 Jan; 6():19076. PubMed ID: 26743949
[TBL] [Abstract][Full Text] [Related]
20. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
